BIOSTATISTICS CORE
生物统计学核心
基本信息
- 批准号:8245888
- 负责人:
- 金额:$ 23.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-09-01 至 2013-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAllograftingAreaBiologicalBiostatistics CoreClinicalClinical ProtocolsClinical ResearchClinical TrialsClinical Trials DesignCollaborationsDataData AnalysesDevelopmentDrug FormulationsExperimental DesignsGrantImmunobiologyLaboratoriesLaboratory StudyMarrowMemorial Sloan-Kettering Cancer CenterMethodologyPhasePopulationPrincipal InvestigatorProceduresProgram Research Project GrantsProtocols documentationRandomizedResearchResearch PersonnelRoleSafetySample SizeTranslatinganticancer researchbasedesignleukemiamemberpre-clinicalpreclinical studyprimary outcomeprogramsresearch study
项目摘要
The role of the biostatistics core is to support the investigators of this leukemia grant in their research efforts,
including laboratory experiments, and the design and analysis of clinical trials. In preclinical studies, core
members will assist in the formulation of the experimental design and in the analysis and interpretation of the
data at the conclusion of the study. In the clinical trial design phase, a core member will assist the principal
investigator in the development of a clinical protocol. At the conclusion of the clinical trial, data analyses will
be performed to assess outcomes of the primary and secondary endpoints stated in the protocol. In addition,
retrospective data analyses will be performed to address specific clinical research questions. If the current
statistical methodology does not adequately address a research question in this grant, alternative
methodologies will be explored. .
The specific aims of the Biostatistics Core are to:
1. contribute to the design and analysis of the laboratory studies;
2. contribute to the design and analysis of the clinical studies; -
3. develop statistical methodology that will assist in the advancement of leukemia cancer research.
Relevance: The Biostatistics Core is essential to the design, ongoing review and final analysis of preclinical
experiments and clinical trials to translate biological questions into experimentally testable hypotheses
yielding interpretable results and to insure that planned clinical trials are feasible, invoke appropriate design
and stopping rules to insure safety and are appropriately analyzed and interpreted.
生物统计核心的作用是支持白血病基金的研究人员的研究工作,
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Glenn Heller其他文献
Glenn Heller的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Glenn Heller', 18)}}的其他基金
Inferential methods to assess the incremental value of new biomarkers in risk classification models
评估风险分类模型中新生物标志物增量价值的推理方法
- 批准号:
9309399 - 财政年份:2017
- 资助金额:
$ 23.41万 - 项目类别:
相似海外基金
Establishment of novel osteochondral allografting combined with growth factor- collagen-binding domain fusion technology
新型同种异体骨软骨移植联合生长因子-胶原蛋白结合域融合技术的建立
- 批准号:
26462277 - 财政年份:2014
- 资助金额:
$ 23.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Translating PTH Therapy as an Adjuvant for Structural Allografting
将 PTH 疗法转化为结构性同种异体移植的佐剂
- 批准号:
8344380 - 财政年份:2012
- 资助金额:
$ 23.41万 - 项目类别:
Composite Allografting for Promoting Survival of Corneal Transplants
复合同种异体移植促进角膜移植的存活
- 批准号:
7878675 - 财政年份:2009
- 资助金额:
$ 23.41万 - 项目类别:
Composite Allografting for Promoting Survival of Corneal Transplants
复合同种异体移植促进角膜移植的存活
- 批准号:
7677758 - 财政年份:2009
- 资助金额:
$ 23.41万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
7466112 - 财政年份:2008
- 资助金额:
$ 23.41万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
8010394 - 财政年份:2008
- 资助金额:
$ 23.41万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
8208131 - 财政年份:2008
- 资助金额:
$ 23.41万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
7575273 - 财政年份:2008
- 资助金额:
$ 23.41万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
7765518 - 财政年份:2008
- 资助金额:
$ 23.41万 - 项目类别:














{{item.name}}会员




